645 Matching Annotations
  1. May 2021
    1. 2021-05-10

    2. Huang, L., & Cao, B. (2021). Post-acute conditions of patients with COVID-19 not requiring hospital admission. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(21)00225-5

    3. 10.1016/S1473-3099(21)00225-5
    4. As of early April, 2021, more than 2·8 million individuals have died globally from COVID-19. However, tens of millions of patients have survived COVID-19 and returned to everyday life. Increasing evidence has shown that a considerable proportion of patients did not recover fully and had lasting sequelae, described by various terms without consensus, including long COVID, post-COVID condition or syndrome, postacute (or late) sequelae of COVID-19, and post-acute COVID syndrome.1Lerner AM Robinson DA Yang L et al.Toward understanding COVID-19 recovery: National Institutes of Health workshop on postacute COVID-19.Ann Intern Med. 2021; (published online March 30.)https://doi.org/10.7326/M21-1043Crossref PubMed Google Scholar,  2Nalbandian A Sehgal K Gupta A et al.Post-acute COVID-19 syndrome.Nat Med. 2021; 27: 601-615Crossref PubMed Scopus (1) Google Scholar Studies have mainly focused on patients with COVID-19 after hospital admission.3Huang C Huang L Wang Y et al.6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.Lancet. 2021; 397: 220-232Summary Full Text Full Text PDF PubMed Scopus (51) Google Scholar,  4Morin L Savale L Pham T et al.Four-month clinical status of a cohort of patients after hospitalization for COVID-19.JAMA. 2021; (published online March 17.)https://doi.org/10.1001/jama.2021.3331PubMed Google Scholar One study with a small sample size and without a control group of people without COVID-19 described the long-term outcomes of patients with COVID-19 who did not require hospital admission.5Stavem K Ghanima W Olsen MK Gilboe HM Einvik G Persistent symptoms 1·5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.Thorax. 2020; 76: 405-407Crossref Scopus (8) Google Scholar
    5. Post-acute conditions of patients with COVID-19 not requiring hospital admission
    1. 2021-05-10

    2. Vaughan, A. (2021, May 10). Indian coronavirus variant in the UK seems to be more transmissible. New Scientist. https://www.newscientist.com/article/2277153-indian-coronavirus-variant-in-the-uk-seems-to-be-more-transmissible/

    3. A form of the coronavirus variant first identified in India, which is now spreading in the UK, appears to be passed on at least as easily as the “Kent variant” that now dominates UK infections. The variant, called B.1.617.2, was designated a “variant of concern” on 7 May by health authorities in England. B.1.617.2 is one of three sub-lineages of B.1.617, the variant that has become common in India and which some have considered, but not proven, to be one potential factor behind the crisis India has been facing. On 10 May, the World Health Organization designated B.1.617 as a variant of concern. Advertisement googletag.cmd.push(function() { googletag.display('mpu-mid-article'); }); googletag.cmd.push(function() { googletag.display('video-mid-article'); }); Public Health England (PHE) has moderate confidence that the B.1.617.2 variant is on a par for transmissibility with B.1.1.7, which originated in the UK, said Sharon Peacock at the University of Cambridge at a press briefing today. The view is based on the variant’s mutations and its ability to circulate in the UK alongside the Kent variant. However, there is still much we don’t know about the Indian variants.
    4. Indian coronavirus variant in the UK seems to be more transmissible
    1. 2021-05-11

    2. WIlliams, S. N., & Dienes, K. (2021). Public attitudes to COVID-19 vaccines: A qualitative study. PsyArXiv. https://doi.org/10.31234/osf.io/h87s3

    3. 10.31234/osf.io/h87s3
    4. OBJECTIVE: To explore public attitudes to COVID-19 vaccines in the UK, focused on intentions and decisions around taking vaccines, views on ‘vaccine passports’, and experiences and perspectives on post-vaccination behaviour. DESIGN: Qualitative study consisting of 6 online focus groups conducted between 15th March – 22nd April 2021. SETTING: Online video conferencing PARTICIPANTS: 29 adult UK-based participants RESULTS: Three main groups regarding participants’ decision or intention to receive a COVID-19 vaccine were identified: (1) Accepters, (2) Delayers and (3) Refusers. Two reasons for vaccine delay were identified: delay due to a perceived need more information and delay until vaccine was “required” in the future. Three main facilitators (Vaccination as a social norm; Vaccination as a necessity; Trust in science) and six barriers (Preference for “natural immunity”; Concerns over possible side effects; Distrust in government; Perceived lack of information; Conspiracy theories; “Covid echo chambers”) to vaccine uptake were identified. For some delayers, 'vaccine passports' were perceived to be a reason why they would get vaccinated in the future. However, vaccine passports were controversial, and were framed in four main ways: as “a necessary evil”; as “Orwellian”; as a “human rights problem”; and as a source of confidence”. Participants generally felt that receiving a vaccine was not changing the extent to which people were adhering to COVID-19 measures. CONCLUSIONS: Overall positive sentiment around vaccines is high. However, there remains a number of potential barriers which might be leading to vaccine delay in some. ‘Vaccine delay’ might be a more useful and precise construct than vaccine hesitancy in explaining why some may initially ignore or be uncertain about vaccination invitations. Vaccine passports may increase or ‘nudge’ uptake in some delayers but may be unpopular in others. Earlier concerns that vaccination might reduce adherence to social distancing measures are not borne out in our data, with most people reporting adherence and caution.
    5. Public attitudes to COVID-19 vaccines: A qualitative study
    1. 2021-04-30

    2. Moutinho, S., WadmanApr. 30, M., 2021, & Pm, 5:40. (2021, April 30). Is Russia’s COVID-19 vaccine safe? Brazil’s veto of Sputnik V sparks lawsuit threat and confusion. Science | AAAS. https://www.sciencemag.org/news/2021/04/russias-covid-19-vaccine-safe-brazils-veto-sputnik-v-sparks-lawsuit-threat-and

    3. A confusing and unusually nasty fight broke out this week over the safety of a Russian COVID-19 vaccine known as Sputnik V after a Brazilian health agency declined on Monday to authorize its import because of quality and safety concerns. The stakes escalated yesterday when the Twitter account officially associated with the vaccine said “Sputnik V is undertaking a legal defamation proceeding” against Brazil’s regulators. In an online press conference several hours later, the Brazilian Health Regulatory Agency (Anvisa) defended its decision, maintaining that documentation from some of the Russian facilities making Sputnik V shows that one of its two doses contains adenoviruses capable of replication, a potential danger to vaccine recipients. The vaccine uses two different adenoviruses, which cause the common cold, to deliver the gene for the spike protein of SARS-CoV-2, the virus that causes COVD-19. Both are supposed to be stripped of a key gene that allows them to replicate.
    4. Is Russia’s COVID-19 vaccine safe? Brazil’s veto of Sputnik V sparks lawsuit threat and confusion
    1. 2021-04-26

    2. Why Black And Latino People Still Lag On COVID Vaccines—And How To Fix It. (n.d.). NPR.Org. Retrieved May 6, 2021, from https://www.npr.org/sections/health-shots/2021/04/26/989962041/why-black-and-latino-people-still-lag-on-covid-vaccines-and-how-to-fix-it

    3. There are a lot of ways Dr. Kent Bream would describe the lines of people waiting, sometimes for hours, for COVID-19 vaccines at his community health clinic in West Philadelphia. Eager. Impatient. Frustrated, even. But "hesitant" doesn't come to mind. As soon as the city started sending him doses, he says, demand was never an issue. In fact, Bream's clinic — which is located in a predominantly Black neighborhood — had more vaccines than it had staff to administer them. "I said, send me vaccine and I will show you that there is not the level of vaccine hesitancy you think there is," recalls the medical director of Sayre Health Center. Despite the high demand, the latest data show that 23% of vaccines are going to Black residents. Compare that to Philadelphia's total population, which is more than 40% Black. Vaccination rates for Black and Latino people in the city are still half what they are for whites.
    4. Why Black And Latino People Still Lag On COVID Vaccines — And How To Fix It
    1. 2020-07-13

    2. Rothmund, T., Farkhari, F., Azevedo, F., & Ziemer, C.-T. (2020). Scientific Trust, Risk Assessment, and Conspiracy Beliefs about COVID-19—Four Patterns of Consensus and Disagreement between Scientific Experts and the German Public. PsyArXiv. https://doi.org/10.31234/osf.io/4nzuy

    3. 10.31234/osf.io/4nzuy
    4. We investigated laypersons’ agreement with technical claims about the spread of the Sars-CoV-2 virus and with claims about the risk from COVID-19 in the general public in Germany (N = 1,575) and compared these with the evaluations of scientific experts (N = 128). Using Latent Class Analysis, we distinguished four segments in the general public. Two groups (mainstream and cautious, 73%) are generally consistent with scientific experts in their evaluations. Two groups (doubters and deniers, 27%) differ distinctively from expert evaluations and tend to believe in conspiracies about COVID-19. Deniers (8%) are characterized by low risk assessments, anti-elitist sentiments and low compliance with containment measures. Doubters (19%) are characterized by general uncertainty in the distinction between true and false claims and by low scientific literacy in terms of cognitive ability and style. Our research indicates that conspiracy beliefs about COVID-19 cannot be linked to a single and distinct motivational structure.
    5. Scientific Trust, Risk Assessment, and Conspiracy Beliefs about COVID-19 - Four Patterns of Consensus and Disagreement between Scientific Experts and the German Public
    1. 2021-05-06

    2. Rohrer, J. M., Schmukle, S., & McElreath, R. (2021). The Only Thing That Can Stop Bad Causal Inference Is Good Causal Inference. PsyArXiv. https://doi.org/10.31234/osf.io/mz5jx

    3. 10.31234/osf.io/mz5jx
    4. In psychology, causal inference—both the transport from lab estimates to the real world and estimation on the basis of observational data—is often pursued in a casual manner. Underlying assumptions remain unarticulated; potential pitfalls are compiled in post-hoc lists of flaws. The field should move on to coherent frameworks of causal inference and generalizability that have been developed elsewhere.
    5. The Only Thing That Can Stop Bad Causal Inference Is Good Causal Inference
  2. Apr 2021
    1. 2021-04-21

    2. ReconfigBehSci. (2021, April 21). RT @covidoneyearago: One year ago today: A paper in Clinical Infectious Diseases identifies a 16.3% rate of in-household COVID-19 infection… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1384784541873737729

    3. One year ago today: A paper in Clinical Infectious Diseases identifies a 16.3% rate of in-household COVID-19 infection, with a 21% rate in adults and 4% in children. Among cases where the first household member to be infected self-quarantined at home, the rate was 0%.
    1. 2021-04-21

    2. Teodorescu, K., Plonsky, O., Ayal, S., & Barkan, R. (2021). Enforcement policies: Frequency of inspection is more important than the severity of punishment. PsyArXiv. https://doi.org/10.31234/osf.io/pbvzr

    3. 10.31234/osf.io/pbvzr
    4. External enforcement policies aimed to reduce violations differ on two key components: the probability of inspection and the severity of punishments. Different lines of research offer competing predictions regarding the relative importance of each component. In three incentive compatible studies, students and Prolific crowdsourcing participants (Ntotal=430) repeatedly faced temptations to commit violations under two enforcement policies. Controlling for expected value, the results indicated that a policy combining High probability of Inspection with Low Severity of fine (HILS) was more effective than a policy combining Low probability of Inspection with High Severity of fine (LIHS). Consistent with the prediction of Decisions from Experience research, this finding held even when the severity of the fine was stated in advance to boost deterrence. In addition, the advantage of HILS over LIHS was greater as participants’ baseline rate of violation (without enforcement) was higher, implying that HILS is more effective among frequent offenders.
    5. Enforcement policies: Frequency of inspection is more important than the severity of punishment
    1. 2021-04-20

    2. Cardno, S. J., & Sahraie, A. (2021). The expanding backlog of mental health patients: Time for a major rethink in COVID-19 policy. PsyArXiv. https://doi.org/10.31234/osf.io/st5b2

    3. 10.31234/osf.io/st5b2
    4. ● Prior to the pandemic there was a 4-5% annual rise in the number of mental health related GP referrals in Scotland. ● There was a 27% drop in referrals in 2020, affecting 43,522 patients. ● Previous pandemic related research shows that restrictions imposed to curb infections led to higher incidence of mental health problems and therefore it is likely that the true figure of those in need of referral far exceeds this figure. ● If the mental health services are restored to their pre-pandemic levels, the tens of thousands of patients who have not been referred yet, will face years on waiting lists before specialist help can be provided. ● There is an urgent need to re-evaluate COVID imposed restrictions on the operations of NHS services to address the challenges.
    5. The expanding backlog of mental health patients: Time for a major rethink in COVID-19 policy
    1. 2021-04-23

    2. Saad-Roy, C. M., Morris, S. E., Metcalf, C. J. E., Mina, M. J., Baker, R. E., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Levin, S. A., Grenfell, B. T., & Wagner, C. E. (2021). Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes. Science, 372(6540), 363–370. https://doi.org/10.1126/science.abg8663

    3. INTRODUCTIONAs the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues, the deployment of safe and effective vaccines presents a key intervention for mitigating disease severity and spread. Numerous logistical challenges and shortages have emerged alongside the international distribution of approved vaccines. In response, several countries have chosen to delay the second dose in an effort to increase the number of individuals receiving at least one dose. A key question then becomes how the timing of delivery of the second dose will affect future epidemiological and evolutionary outcomes.RATIONALEWe build on an existing immuno-epidemiological framework that assumes that, without vaccination, individual immunity after recovery from primary infection may eventually wane, leading to (a potentially reduced) susceptibility to secondary infections. To explore epidemiological outcomes, we extend the model to incorporate two vaccinated classes, corresponding to individuals who have received either one dose or two doses of a SARS-CoV-2 vaccine. As with natural immunity, we allow for one- or two-dose vaccinal immunity to wane, and we consider a continuous spectrum for the interdose period between vaccines. To reflect the increase in available doses resulting from a delayed second dose, we model the rate of administration of the first dose as an increasing function of the interdose period. We then consider evolutionary outcomes by coupling this framework to a simple phylodynamic model for potential viral adaptation under different evolutionary scenarios, each with its own assumptions regarding viral abundance and within-host selection for the different partially susceptible classes.RESULTSWe find that delaying second vaccine doses reduces COVID-19 infections in the short term by increasing the proportion of immune individuals. In the longer term, however, both the infection burden and the relative potential for viral adaptation are highly dependent on the robustness of natural or vaccinal immune responses. Notably, we find that even if immunity conferred by a single vaccine dose is poor, starting with a one-dose policy early on to increase the number of individuals immunized and then switching to the manufacturer-recommended two-dose regime as vaccine capacity increases can mitigate potential negative longer-term epidemiological and evolutionary outcomes. This mitigation can also be achieved by ramping up overall vaccination rates as availability improves.CONCLUSIONThe deployment of SARS-CoV-2 vaccines will strongly shape postpandemic epidemiological trajectories and characteristics of accumulated population immunity. Our models show that the combination of different vaccine dosing regimes and variations in the robustness of natural and vaccinal immunity may result in a wide range of potential epidemiological and evolutionary outcomes in the medium term. It is therefore imperative to determine the strength and duration of clinical protection and transmission-blocking immunity through careful clinical evaluations in order to enforce sound public policies. In places where vaccine deployment is delayed and vaccination rates are low, our results stress the subsequent negative epidemiological and evolutionary impacts that may emerge. Particularly because these consequences (for example, the evolution of new variants) could emerge as global problems, there is an urgent need for global equity in vaccine distribution and deployment.
    4. 10.1126/science.abg8663
    5. Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
    1. 2021-04-23

    2. One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – study. (2021, April 22). The Guardian. http://www.theguardian.com/society/2021/apr/23/one-dose-of-pfizer-or-oxford-jab-reduces-covid-infection-rate-by-65-study

    3. One shot of the Oxford/AstraZeneca or Pfizer/BioNTech vaccine reduces coronavirus infections by nearly two-thirds and protects older and more vulnerable people as much as younger, healthy individuals, a study has found.The results from Oxford University and the Office for National Statistics are a welcome boost to the vaccination programme and the first to show the impact on new infections and immune responses in a large group of adults in the general population.By driving down rates of infection the vaccines will not only prevent hospitalisations and deaths but help break chains of transmission and so reduce the risk of a damaging resurgence of disease as the UK reopens.
    4. One dose of Pfizer or Oxford jab reduces Covid infection rate by 65% – study
    1. 2021-04-09

    2. Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leschinsky, M., Dror, S. K., Bergerzon, G., Gadban, H., Gadban, F., Eliassian, E., Shimron, O., Saleh, L., Ben-Zvi, H., Amichay, D., Ben-Dor, A., … Stern, A. (2021). Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals. MedRxiv, 2021.04.06.21254882. https://doi.org/10.1101/2021.04.06.21254882

    3. 10.1101/2021.04.06.21254882
    4. The SARS-CoV-2 pandemic has been raging for over a year, creating global detrimental impact. The BNT162b2 mRNA vaccine has demonstrated high protection levels, yet apprehension exists that several variants of concerns (VOCs) can surmount the immune defenses generated by the vaccines. Neutralization assays have revealed some reduction in neutralization of VOCs B.1.1.7 and B.1.351, but the relevance of these assays in real life remains unclear. Here, we performed a case-control study that examined whether BNT162b2 vaccinees with documented SARS-CoV-2 infection were more likely to become infected with B.1.1.7 or B.1.351 compared with unvaccinated individuals. Vaccinees infected at least a week after the second dose were disproportionally infected with B.1.351 (odds ratio of 8:1). Those infected between two weeks after the first dose and one week after the second dose, were disproportionally infected by B.1.1.7 (odds ratio of 26:10), suggesting reduced vaccine effectiveness against both VOCs under different dosage/timing conditions. Nevertheless, the B.1.351 incidence in Israel to-date remains low and vaccine effectiveness remains high against B.1.1.7, among those fully vaccinated. These results overall suggest that vaccine breakthrough infection is more frequent with both VOCs, yet a combination of mass-vaccination with two doses coupled with non-pharmaceutical interventions control and contain their spread.
    5. Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
    1. 2021-03-17

    2. Rubin, R. (2021). COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough. JAMA, 325(13), 1241. https://doi.org/10.1001/jama.2021.3370

    3. 10.1001/jama.2021.3370
    4. As COVID-19 cases resulting from infection with SARS-CoV-2 variants accumulate in the US and around the world, one question looms large: How well do the COVID-19 vaccines developed so far protect against these novel coronavirus spinoffs? “The virus is telling us it’s going to throw out a lot of mutations,” infectious disease specialist Jesse Goodman, MD, MPH, who, as then-chief scientist at the US Food and Drug Administration (FDA), led the agency’s response to the H1N1 influenza A pandemic, said in an interview. “Even if we don’t have a critical situation right at the moment…there’s a realistic possibility that variants will continue to evolve that have potential to avoid vaccine immunity.” That’s to be expected, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID), told JAMA Editor in Chief Howard Bauchner, MD, in a February 3 podcast. Regardless of the platform on which the vaccine is based, Fauci said, “you still have a fixed immunogen and a virus that’s changing. Sooner or later, you’re going to get a mutant that evades that.”
    5. COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough
    1. 2021-04-09

    2. Kubo, T., Sugawara, D., & Masuyama, A. (2021). The effect of passion for activities on fear of COVID-19 and mental health among the Japanese population. PsyArXiv. https://doi.org/10.31234/osf.io/rvgs7

    3. 10.31234/osf.io/rvgs7
    4. As the pandemic limited our lives, people engaged in their favorite activities; either in alternative ways or while disregarding the restrictions. These major activities and our engagement in these activities of life are considered to have a significant impact on our mental health. Thus, this study aimed to examine the relationship between two types of passion (harmonious passion and obsessive passion), fear of COVID-19 (emotional fear responses, symptomatic expressions of fear), and mental distress. To this end, 322 Japanese participants completed an online questionnaire. The results showed that harmonious passion (HP) was positively related to emotional fear responses and negatively to mental distress. On the other hand, obsessive passion (OP) was positively associated with symptomatic expressions of fear and negatively with mental distress. Symptomatic expressions of fear have a stronger positive relationship with mental distress than emotional fear reactions. This study evidenced that HP is a protective factor against pandemics as it improves mental health while appropriately recognizing fear of COVID-19. Focusing on different types of passion may prove effective in improving mental health amidst the pandemic.
    5. The effect of passion for activities on fear of COVID-19 and mental health among the Japanese population
    1. 2021-04-07

    2. De Block Golding, D. (2021, April 7). Viral video contains several false pandemic claims. Full Fact. https://fullfact.org/health/viral-video-contains-several-false-pandemic-claims/

    3. A viral video on Facebook includes a number of false and misleading claims about the Covid-19 pandemic.  The video consists of a woman recommending a publication in New Zealand called The Real News, which she summarises and reads from. There are a number of false or misleading claims in this video. This article considers some of them. There are  many other claims included in the video that we have not checked, which may or may not be true. 
    4. Viral video contains several false pandemic claims
    1. 2021-04-01

    2. Huang, P. (2021, April 1). How The CDC Is Battling The Pandemic And Working To Regain Public Trust: Shots—Health News: NPR. https://www.npr.org/sections/health-shots/2021/04/01/982761755/inside-the-cdcs-battle-to-defeat-the-virus?utm_campaign=storyshare&utm_source=twitter.com&utm_medium=social

    3. The CDC's sweeping COVID-19 response has involved teams deployed to trace outbreaks in vulnerable communities, consultations with hospitals and schools to mitigate transmission, embeds and trainings with state and local health departments, coordinating vaccine distribution, and major efforts to wrangle data from disparate sources to paint a clear picture of the pandemic's trajectory. For much of the pandemic, the work has been largely invisible to the public. The agency was sidelined and contradicted by the Trump administration, leading to mixed messaging on topics such as mask use, school reopenings and testing.
    4. Inside The CDC's Battle To Defeat The Virus
  3. Mar 2021
    1. 2021-03-01

    2. Curtius, J., Granzin, M., & Schrod, J. (2021). Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2. Aerosol Science and Technology, 55(5), 586–599. https://doi.org/10.1080/02786826.2021.1877257

    3. Airborne transmission of SARS-CoV-2 through virus-containing aerosol particles has been established as an important pathway for Covid-19 infection. Suitable measures to prevent such infections are imperative, especially in situations when a high number of persons convene in closed rooms. Here we tested the efficiency and practicability of operating four air purifiers equipped with HEPA filters in a high school classroom while regular classes were taking place. We monitored the aerosol number concentration for particles >3 nm at two locations in the room, the aerosol size distribution in the range from 10 nm to 10 µm, PM10 and CO2 concentration. For comparison, we performed similar measurements in a neighboring classroom without purifiers. In times when classes were conducted with windows and door closed, the aerosol concentration was reduced by more than 90% within less than 30 min when running the purifiers (air exchange rate 5.5 h−1). The reduction was homogeneous throughout the room and for all particle sizes. The measurements are supplemented by a calculation estimating the maximum concentration levels of virus-containing aerosol from a highly contagious person speaking in a closed room with and without air purifiers. Measurements and calculation demonstrate that air purifiers potentially represent a well-suited measure to reduce the risks of airborne transmission of SARS-CoV-2 substantially. Staying for 2 h in a closed room with a highly infective person, we estimate that the inhaled dose is reduced by a factor of six when using air purifiers with a total air exchange rate of 5.7 h−1.
    4. 10.1080/02786826.2021.1877257
    5. Testing mobile air purifiers in a school classroom: Reducing the airborne transmission risk for SARS-CoV-2
    1. 2021-03-22

    2. Rebitschek, F., Ellermann, C., Jenny, M., Siegel, N. A., Spinner, C., & Wagner, G. (2021). How skeptics could be convinced (not persuaded) to get vaccinated against COVID-19. PsyArXiv. https://doi.org/10.31234/osf.io/f4nqt

    3. 10.31234/osf.io/f4nqt
    4. Central to the SARS-CoV-2 pandemic strategy, COVID-19 vaccination depends on the population’s uptake decisions. Because at least 60% of the population needs to be vaccinated, but fewer, for example, in Germany are expected to do so, it is important to know how to convince those who are undecided or skeptical. According to the health care standard of enabling citizens to make informed decisions based on balanced information (boosting) – instead of persuasion or seduction (nudging) – a comparison of benefits and harms of having or not having the vaccination would be required to inform these groups. With the help of a representative survey, we investigated the contribution of fact boxes, an established intervention format for informed intentions. Study 1 shows the development of knowledge and evaluation of COVID-19 vaccinations by German citizens between Nov 2020 and Feb 2021. Study 2 reveals objective information needs and subjective information requirements of those laypeople at the end of Nov. Study 3 shows that the fact box format is effective for risk communication about COVID-19. Based on these insights, a fact box on the efficacy and safety of mRNA-vaccines was implemented with the help of a national health authority. Study 4 shows that fact boxes increase vaccination knowledge and positive evaluations of the benefit-harm ratio of vaccination in skeptics and undecideds. Our results demonstrate that simple fact boxes can be an effective boost of informed decision making among undecided and skeptical people, and that informed decisions can lead to more positive vaccination evaluations of the public. See less
    5. How skeptics could be convinced (not persuaded) to get vaccinated against COVID-19
    1. 2021-03-23

    2. Kejriwal, M., & Shen, K. (2021). COVID-19 vaccine hesitancy is positively associated with affective wellbeing. PsyArXiv. https://doi.org/10.31234/osf.io/nkvhs

    3. 10.31234/osf.io/nkvhs
    4. SARS-CoV-2 (COVID-19) vaccine hesitancy in the United States is currently at a high level. To enable a better understanding of this hesitancy, this study explores the association between affective wellbeing measures and COVID-19 vaccine hesitancy. We consistently find a positive association between the two, regardless of which of ten different affect state variables (two positive, and eight negative) or their composite, is used. For example, people who experience more worry or anxiety (two negative affect wellbeing states) are less vaccine-hesitant, and vice versa. The association is found to hold even when controlling for potential confounds such as income bracket, political affiliation, gender and employment status. Associations are strongest for the fully employed, and for those in the middle-class income bracket. While consistent at the national level, considerable dispersion is found at the county level. We discuss the implications of these findings briefly. See less
    5. COVID-19 vaccine hesitancy is positively associated with affective wellbeing
    1. 2021-03-18

    2. Schiavone, S. R., Bottesini, J. G., & Vazire, S. (2021). The Crisis from Above: Gatekeepers Need Better Standards. PsyArXiv. https://doi.org/10.31234/osf.io/mby5u

    3. 10.31234/osf.io/mby5u
    4. Improvements to the validity of psychological science depend upon more than the actions of individual researchers. Editors, journals, and publishers wield considerable power in shaping the incentives that have ushered in the generalizability crisis. These gatekeepers must raise their standards to ensure authors’ claims are supported by evidence. Unless gatekeepers change, changes made by individual scientists will not be sustainable.
    5. The Crisis from Above: Gatekeepers Need Better Standards
    1. 2021-03-17

    2. Page, M. L. (2021, March 17). UK variant looks set to cause a surge in global coronavirus cases. New Scientist. https://www.newscientist.com/article/mg24933263-900-uk-variant-looks-set-to-cause-a-surge-in-global-coronavirus-cases/

    3. THE B.1.1.7 coronavirus variant first spotted in the UK is poised to cause a surge in cases worldwide. In many areas of Europe and North America, the variant, which is more transmissible, is now responsible for most new coronavirus infections. Globally, since late February there has been a small uptick in coronavirus infections. Before this, case numbers had been falling sharply. The big question is what happens next.
    4. UK variant looks set to cause a surge in global coronavirus cases
    1. 2021-03-18

    2. Seguin, D., Kuenzel, E., Morton, J. B., & Duerden, E. (2021). School’s out: Parenting stress and screen time use in school-age children during the COVID-19 pandemic. PsyArXiv. https://doi.org/10.31234/osf.io/5guc3

    3. 10.31234/osf.io/5guc3
    4. Background: During the COVID-19 pandemic, millions of children abruptly moved to online schooling, which required high levels of parental involvement. Family routines were disrupted, potentially increasing parental stress, and may be reflected in greater media screen time use in children. Objectives: To determine whether 1) parenting styles and 2) parenting stress were associated with children’s screen time use during the pandemic compared to the pre-pandemic period. Methods: Parents (>18 years of age) were recruited to complete an online survey regarding changes in their children’s (6-12 years) screen time use and daily activities before and during the pandemic. Stress and parental involvement were assessed using the Perceived Stress Scale (PSS) and Alabama Parenting Questionnaires respectively. General linear models assessed whether parenting style and parent stress was associated with children’s screen time during the pandemic, adjusting for demographic variables and daily activities. Results: 104 parents were enrolled, and 78 (75%) parents completed the surveys. Children’s screen time (e.g., watching television and playing video games) increased significantly, from 2.6 hours to 5.8 hours a day (p=.001) during pandemic-related school closures. Smaller changes in children’s screen time use were significantly associated with more parental involvement (p=.017). Parent stress (p=.018) significantly predicted children’s screen time use. Lower household income was associated with increased hours of screen time in both models (both, p<.05). Conclusions: Children’s screen time nearly doubled during the initial months of the pandemic. Parent stress and parenting styles may be modifiable risk factors to promote children’s wellbeing during the ongoing pandemic.
    5. School's out: parenting stress and screen time use in school-age children during the COVID-19 pandemic
    1. 2021-03-18

    2. Petersen, M. B., Jørgensen, F. J., Bor, A., & Lindholt, M. F. (2021). Did the suspension of the AstraZeneca-vaccine decrease vaccine acceptance? PsyArXiv. https://doi.org/10.31234/osf.io/uh4y6

    3. The decision to temporarily suspend the AstraZeneca vaccine against COVID-19 raised debate about the suspension's potential effects on the levels of acceptance of the overall vaccination program against COVID-19. Here, we trace the impact of first the Danish decision and subsequent national decisions on general COVID-19 vaccine acceptance by comparing levels of acceptance on different specific dates in eight countries. Overall, the findings suggest that the Danish decision to suspend the vaccine may have had (at least, short-term) cross-national ripple effects on acceptance of a vaccine against COVID-19. Importantly, these adverse ripple effects were specific for individuals within countries that are most closely tied to the same informational eco-system as Denmark (i.e., other Western European countries). These countries (in particular, Italy) may furthermore have been negatively affected twice following both the Danish and the national suspension decisions. This raises the possibility that the decision to suspend vaccines following adverse events poses a collective action problem and highlights the importance of coordination between national health authorities.
    4. 10.31234/osf.io/uh4y6
    5. Did the suspension of the AstraZeneca-vaccine decrease vaccine acceptance?
    1. 2021-03-17

    2. Lui, P. P., Parikh, K., Katedia, S., & Jouriles, E. (2021). Anti-Asian Discrimination and Antiracist Bystander Behaviors amid the COVID-19 Outbreak. PsyArXiv. https://doi.org/10.31234/osf.io/eaz3k

    3. 10.31234/osf.io/eaz3k
    4. Anti-Asian racism is a public health concern, and it has escalated during the coronavirus disease 2019 (COVID-19) outbreak. Bystanders—individuals who witness acts of racism—can help by discouraging perpetrations of discrimination (and other forms of interpersonal violence), offering help and support to victims, and reinforcing (antiracist) prosocial norms. Yet, little is known about who engages in antiracist bystander intervention behaviors in response to discriminatory events, and who engages in proactive bystander behaviors in general. In the current study, 456 US community adults of diverse ethnic backgrounds (18-85 years, Mage = 48.8, 52.0% women, 212 Asian Americans) reported on their experiences with discrimination, attitudes about the acceptability of discrimination, and engagement in proactive and reactive bystander behaviors. About 40% of the Asian American participants experienced COVID-related discrimination during a one-week period. Among individuals who witnessed anti-Asian discrimination during the COVID-19 outbreak, 45% of them engaged in any antiracist reactive bystander interventions. More frequent everyday discrimination experiences predicted greater odds of reactive bystander behaviors, over and above ethnicity, gender, and attitudes about the acceptability of discrimination. Initial evidence supported the utility of a new measure assessing bystander behaviors in response to racial discrimination. Prior exposure to discrimination may contribute to individuals’ active engagement in antiracist bystander behaviors. Future research directions on antiracist bystander actions and allyship are discussed.
    5. Anti-Asian Discrimination and Antiracist Bystander Behaviors amid the COVID-19 Outbreak
    1. 2021-03-18

    2. Staff, R. (2021, March 18). QUOTES-EU’s drug regulator backs AstraZeneca vaccine after safety investigation. Reuters. https://www.reuters.com/article/health-coronavirus-eu-astrazeneca-idUSL8N2LG602

    3. The EU’s drug watchdog said on Thursday it is still convinced the benefits of AstraZeneca’s COVID-19 vaccine outweigh the risks following an investigation into reports of blood disorders that prompted more than a dozen nations to suspend its use.Following are reactions after the European Medicines Agency (EMA) gave an update on its views on the Oxford-AstraZeneca vaccine.
    4. QUOTES-EU's drug regulator backs AstraZeneca vaccine after safety investigation